OXURION (EBR:OXUR) | WebDisclosure

PRESS RELEASE

published on 08/04/2025 at 18:00, 7 months 18 days ago

Oxurion kondigt aan dat het een verbeterd indicatief financieringsaanbod van EUR 30 miljoen heeft gekregen om de diversificatie van een deel van zijn kasmiddelen naar digitale activa te starten
Oxurion NV ontvangt een verbeterd financieringsaanbod van €30 miljoen van Atlas Special Opportunities voor investering in digitale activa. Financiering in tien schijven via converteerbare obligaties om kasmiddelen te diversifiëren

Atlas Special Opportunities Oxurion NV Converteerbare Obligaties Financieringsaanbod Digitale Activa
PRESS RELEASE

published on 08/04/2025 at 18:00, 7 months 18 days ago

Oxurion announces it obtained an improved indicative EUR 30 million financing offer to initiate its plan to diversify by allocating part of its treasury into digital assets
Oxurion NV receives €30 million financing offer from Atlas Special Opportunities for investment in digital assets. Company remains confident in closing the transaction by August 2025

Investment Digital Assets Oxurion NV Financing Offer August 2025
BRIEF

published on 08/04/2025 at 08:35, 7 months 18 days ago

Oxurion conclut l'acquisition de 72% d'Axiodis CRO

Acquisition Croissance Externe Données Cliniques Oxurion Axiodis CRO
BRIEF

published on 08/04/2025 at 08:35, 7 months 18 days ago

Oxurion completes acquisition of 72% of Axiodis CRO

Acquisition External Growth Clinical Data Oxurion Axiodis CRO
PRESS RELEASE

published on 08/04/2025 at 08:30, 7 months 18 days ago

Oxurion finalise l'acquisition d'Axiodis CRO et accélère la structuration de son pôle européen dédié à la donnée clinique
Oxurion finalise l'acquisition de 72?% du capital d'Axiodis CRO, marquant la première étape vers un pôle intégré de donnée clinique en France et en Europe

Acquisition Stratégie De Croissance Biopharmaceutique Donnée Clinique Oxurion
PRESS RELEASE

published on 08/04/2025 at 08:30, 7 months 18 days ago

Oxurion completes the acquisition of Axiodis CRO and accelerates the structuring of its European clinical data platform
Oxurion completes the acquisition of 72% stake in Axiodis CRO, paving the way for an integrated platform focused on clinical data. Intensifies discussions with strategic targets in France and Europe

Acquisition Europe Intégration Clinical Data Oxurion
PRESS RELEASE

published on 08/04/2025 at 08:30, 7 months 18 days ago

Oxurion rondt overname van Axiodis CRO af en versnelt uitbouw van haar Europese platform voor klinische data
Oxurion schliesst erfolgreich die Übernahme von 72% des Aktienkapitals von Axiodis CRO ab und beschleunigt die Gespräche mit strategischen Partnern zur Schaffung eines integrierten Plattforms für klinische Daten

Übernahme Partnerschaften Oxurion Axiodis CRO Klinische Daten
BRIEF

published on 07/30/2025 at 18:05, 7 months 23 days ago

Oxurion Réceptionne une Notification de Transparence Modifiée

Actions Transparence Atlas Special Opportunities Oxurion Bio-pharmaceutique
BRIEF

published on 07/30/2025 at 18:05, 7 months 23 days ago

Oxurion Receives a Modified Transparency Notification

Actions Transparency Biopharmaceutical Atlas Special Opportunities Oxurion
PRESS RELEASE

published on 07/30/2025 at 18:00, 7 months 23 days ago

Oxurion ontvangt aangepaste transparantiekennisgeving van Atlas Special Opportunities II LLC
Oxurion NV receives transparency notification from Atlas Special Opportunities II LLC regarding shareholding threshold

Transparency Notification Shareholding Belgium Oxurion NV Atlas Special Opportunities II LLC

Published on 03/23/2026 at 02:00, 3 hours 1 minute ago

FutureGen Industries Announces Open Market Investments
Published on 03/20/2026 at 23:00, 2 days 6 hours ago

Cypher Announces Private Placement
Published on 03/20/2026 at 21:30, 2 days 7 hours ago

Sky Gold Sets Options
Published on 03/20/2026 at 21:15, 2 days 7 hours ago

Earthwise Minerals Announces Private Placement
Published on 03/20/2026 at 13:30, 2 days 15 hours ago

Unusual Machines Announces Pricing of Approximately $150 Million Public Offering of Common Stock

View all ACCESSWIRE

Published on 03/23/2026 at 03:35, 1 hour 26 minutes ago

Deye 2026 Frankfurt Distributor & Partner Summit Concludes Successfully
Published on 03/22/2026 at 18:22, 10 hours 39 minutes ago

Test news - please ignore EN
Published on 03/22/2026 at 12:23, 16 hours 38 minutes ago

Borussia Dortmund and Sebastian Kehl are ending their collaboration with immediate effect
Published on 03/20/2026 at 22:45, 2 days 6 hours ago

Investor Alert: Berger Montague (Canada) PC represents investors that purchased shares of Super Micro Computer, Inc. listed on the CBOE Canada and elsewhere
Published on 03/20/2026 at 21:05, 2 days 7 hours ago

Fractal EMS Receives ISO/IEC 9001 and 27001 Certifications

View all EQS

Published on 03/20/2026 at 19:00, 2 days 10 hours ago

AXA - Conditions for availability or consultation of information relating to AXA’s Shareholders’ Meeting of April 30, 2026
Published on 03/20/2026 at 19:00, 2 days 10 hours ago

AXA - Modalités de mise à disposition ou de consultation des informations relatives à l’Assemblée Générale du 30 avril 2026
Published on 03/20/2026 at 18:15, 2 days 10 hours ago

Publication of AXA’s 2025 Universal Registration Document
Published on 03/20/2026 at 18:15, 2 days 10 hours ago

Mise à disposition du Document d’Enregistrement Universel 2025 d’AXA
Published on 03/20/2026 at 17:45, 2 days 11 hours ago

Cie du Bois Sauvage : Jaarverslag 2025

View all LES ECHOS COMFI WIRE

News